Evidence map›Paper›PMID 30069477›Full record

SynthesisBioMed research international2018

A Meta-Analysis of Therapeutic Efficacy and Safety of Gabapentin in the Treatment of Postherpetic Neuralgia from Randomized Controlled Trials.

Meng Zhang, Cun-Xiang Gao, Ke-Tao Ma, Li Li, Zhi-Gang Dai, Sheng Wang, Jun-Qiang Si

Registry-linked trialOpen access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06893172 (Effectiveness of Warm Acupuncture for Postherpetic Neuralgia in the Context of the Qi Stagnation and Blood Stasis Syndrome), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06893172 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Effectiveness of Warm Acupuncture for Postherpetic Neuralgia in the Context of the Qi Stagnation and Blood Stasis Syndrome: a Randomized Controlled Trial

TypeinterventionalSponsorUniversity of Medicine and Pharmacy at Ho Chi Minh CityRan2025 to 2025Enrolled36ConditionsPostherpetic Neuralgia ( PHN )ArmsWarm acupuncture and Gabapentin, Gabapentin
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Meng ZhangDepartment of Anesthesiology, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi 832002, China.ORCID 0000-0002-4401-9382
Cun-Xiang GaoDepartment of Urology, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi 832002, China.
Ke-Tao MaElectrophysiological Laboratory, Laboratory of Xinjiang Endemic and Ethnic Diseases, China.
Li LiElectrophysiological Laboratory, Laboratory of Xinjiang Endemic and Ethnic Diseases, China.
Zhi-Gang DaiDepartment of Anesthesiology, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi 832002, China.
Sheng WangDepartment of Anesthesiology, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi 832002, China.
Jun-Qiang SiElectrophysiological Laboratory, Laboratory of Xinjiang Endemic and Ethnic Diseases, China.ORCID 0000-0002-3275-1701
Shihezi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe study aims to systematically evaluate the clinical effect of gabapentin in the treatment of postherpetic neuralgia (PHN).

methodData were retrieved electronically from PubMed, Embase, CNKI, the China Biomedical Database, and the Library of Clinical Database, beginning from the time of inception to April 2017, in order to collect data on randomized controlled trials (RCTs) of gabapentin and placebo in PHN treatment.

resultsA total of 11 RCTs (2376 people) were retrieved. The gabapentin group reported significantly reduced pain intensity [MD=-0.91, 95% CI -1.32 to -0.51, P<0.00001] compared with the placebo group. Those treated with gabapentin also experienced significantly improved sleep quality [SMD=-0.44, 95% CI -0.66 to -0.23, P<0.0001], but were more likely to experience incidence of adverse events, such as somnolence, dizziness, and peripheral edema. Results of the subgroup analysis showed that the source of heterogeneity may be related to the formulations of the drug.

conclusionGabapentin can be used to effectively and safely treat PHN.

Indexed as

AminesAnalgesicsCyclohexanecarboxylic AcidsGabapentingamma-Aminobutyric AcidHumansNeuralgia, PostherpeticRandomized Controlled Trials as TopicAminesAnalgesicsCyclohexanecarboxylic AcidsGabapentingamma-Aminobutyric Acid

Identifiers

PMID30069477
PMCPMC6057412
OpenAlexW2810291588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.